Marc Engelhardt

3.3k total citations
69 papers, 1.8k citations indexed

About

Marc Engelhardt is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Marc Engelhardt has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 19 papers in Epidemiology and 15 papers in Oncology. Recurrent topics in Marc Engelhardt's work include Antifungal resistance and susceptibility (16 papers), Glioma Diagnosis and Treatment (12 papers) and Fungal Infections and Studies (10 papers). Marc Engelhardt is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Glioma Diagnosis and Treatment (12 papers) and Fungal Infections and Studies (10 papers). Marc Engelhardt collaborates with scholars based in Switzerland, United States and Germany. Marc Engelhardt's co-authors include Mikael Saulay, M. Azria, Jarosław D. Kasprzak, Adrian C. Borges, Harald Becher, Jean‐Louis Vanoverschelde, Christian Firschke, Linda Mindeholm, Stuart L. Silverman and C. H. Chesnut and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Marc Engelhardt

64 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Engelhardt Switzerland 21 643 618 297 270 226 69 1.8k
Burkhard Kreft Germany 27 582 0.9× 309 0.5× 195 0.7× 658 2.4× 450 2.0× 144 2.9k
Alessandro Re Italy 28 325 0.5× 308 0.5× 87 0.3× 135 0.5× 359 1.6× 110 2.3k
Seiya Kato Japan 30 753 1.2× 682 1.1× 192 0.6× 114 0.4× 757 3.3× 164 3.0k
Kevin A. Nash United States 18 1.7k 2.6× 1.2k 1.9× 129 0.4× 194 0.7× 274 1.2× 27 3.3k
Carlo Bonfanti Italy 24 430 0.7× 258 0.4× 198 0.7× 81 0.3× 183 0.8× 90 1.8k
Takashi Niwa Japan 17 220 0.3× 222 0.4× 55 0.2× 372 1.4× 172 0.8× 84 1.4k
Samir Patel United States 29 543 0.8× 214 0.3× 505 1.7× 1.0k 3.8× 160 0.7× 135 2.9k
Qingfeng Sun China 20 441 0.7× 839 1.4× 94 0.3× 271 1.0× 281 1.2× 53 1.9k
Tobias Lahmer Germany 22 426 0.7× 488 0.8× 83 0.3× 65 0.2× 128 0.6× 101 1.5k
Michael Osthoff Switzerland 21 430 0.7× 317 0.5× 45 0.2× 70 0.3× 196 0.9× 94 1.6k

Countries citing papers authored by Marc Engelhardt

Since Specialization
Citations

This map shows the geographic impact of Marc Engelhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Engelhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Engelhardt more than expected).

Fields of papers citing papers by Marc Engelhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Engelhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Engelhardt. The network helps show where Marc Engelhardt may publish in the future.

Co-authorship network of co-authors of Marc Engelhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Engelhardt. A scholar is included among the top collaborators of Marc Engelhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Engelhardt. Marc Engelhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engelhardt, Marc, Florian Kargl, Elke Sondermann, & Andreas Meyer. (2025). Kinetic contributions rule diffusion of mass in the liquid ternary eutectic E1 Ag–Al–Cu alloy. Journal of Physics Condensed Matter. 37(38). 385401–385401.
2.
Segers, Heidi, Jaime G. Deville, William J. Muller, et al.. (2024). Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial. Antimicrobial Agents and Chemotherapy. 68(12). e0048424–e0048424. 7 indexed citations
3.
Necchi, Andrea, Tilman Todenhöfer, Jean‐Laurent Deville, et al.. (2023). Efficacy and safety of derazantinib (DZB) in patients with metastatic urothelial carcinoma (mUC) with activating FGFR1/2/3 genetic aberrations (GA): Results from the phase 1b/2 FIDES-02 study.. Journal of Clinical Oncology. 41(6_suppl). 501–501. 4 indexed citations
4.
Lopez, Juanita, Simon Haefliger, Ruth Plummer, et al.. (2023). Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.. Journal of Clinical Oncology. 41(16_suppl). 2044–2044. 1 indexed citations
5.
Bhavnani, Sujata M., Jeffrey Hammel, Jennifer I. Smart, et al.. (2023). 2531. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Ceftobiprole Dosing Regimens for Patients with Staphylococcus aureus Bacteremia (SAB). Open Forum Infectious Diseases. 10(Supplement_2).
6.
Joerger, Markus, Simon Haefliger, Roger von Moos, et al.. (2023). Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study. Investigational New Drugs. 41(2). 267–275. 1 indexed citations
7.
8.
9.
Nucci, Márcio, Marc Engelhardt, & Kamal Hamed. (2019). Mucormycosis in South America: A review of 143 reported cases. Mycoses. 62(9). 730–738. 38 indexed citations
10.
Joerger, Markus, Anastasios Stathis, Yannis Metaxas, et al.. (2019). A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors. Investigational New Drugs. 38(4). 1067–1076. 6 indexed citations
11.
Scheeren, Thomas, Tobias Welte, Mikael Saulay, et al.. (2019). Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials. BMC Infectious Diseases. 19(1). 195–195. 20 indexed citations
12.
Krol, Ilona, Francesc Castro-Giner, Martina Maurer, et al.. (2018). Detection of circulating tumour cell clusters in human glioblastoma. British Journal of Cancer. 119(4). 487–491. 102 indexed citations
13.
Maertens, Johan, Dominik Selleslag, Werner Heinz, et al.. (2018). Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses. 61(11). 868–876. 8 indexed citations
14.
Groll, Andreas H., Robert Townsend, Amit Desai, et al.. (2017). Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transplant Infectious Disease. 19(5). 95 indexed citations
15.
Ihorst, Gabriele, et al.. (2016). High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy. Urologia Internationalis. 96(4). 399–405. 19 indexed citations
16.
Engelhardt, Marc & Andreas Bührig–Polaczek. (2014). Messung von Diffusionskoeffizienten in ternären AlCuAg-Legierungen und deren Subsystemen. RWTH Publications (RWTH Aachen). 1 indexed citations
17.
Kargl, Florian, et al.. (2011). In situstudies of mass transport in liquid alloys by means of neutron radiography. Journal of Physics Condensed Matter. 23(25). 254201–254201. 29 indexed citations
18.
Chesnut, C. H., M. Azria, Stuart L. Silverman, et al.. (2007). Salmon calcitonin: a review of current and future therapeutic indications. Osteoporosis International. 19(4). 479–491. 162 indexed citations
19.
Schmieder, Kirsten, et al.. (2006). Dynamic Cerebral Autoregulation in Patients with Ruptured and Unruptured Aneurysms after Induction of General Anesthesia. Central European Neurosurgery - Zentralblatt für Neurochirurgie. 67(2). 81–87. 20 indexed citations
20.
Pelinkovic, Dalip, et al.. (2000). Tissue Engineering und Gentherapie des Bewegungsapparates mit Muskelzellen. Zeitschrift für Orthopädie und ihre Grenzgebiete. 138(5). 402–406. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burkhard Kreft Breakdown of academic impact, for papers by Alessandro Re Breakdown of academic impact, for papers by Seiya Kato Breakdown of academic impact, for papers by Kevin A. Nash Breakdown of academic impact, for papers by Carlo Bonfanti Breakdown of academic impact, for papers by Takashi Niwa Breakdown of academic impact, for papers by Samir Patel Breakdown of academic impact, for papers by Qingfeng Sun Breakdown of academic impact, for papers by Tobias Lahmer Breakdown of academic impact, for papers by Michael Osthoff
Rankless by CCL
2026